A growing number of biotech companies are marketing options aimed at prolonging pets' lives, including longevity drugs, pet cloning services, and cryonic preservation. Separately, age-restriction laws meant to keep minors off social media are proving easy to bypass, based on early results from Australia's 2024 ban, even as France, the UK and the EU pursue similar measures.
technologyreview.com
· 2026-10-16
Companies including Loyal are testing longevity drugs for dogs, with one trial involving roughly 1,300 pet dogs in the US targeting metabolic health, alongside other firms developing treatments for age-related conditions like obesity and osteoarthritis, and even cat longevity medicines. Separately, Viagen Pets offers pet cloning for $50,000, producing a genetic twin rather than an exact replica by implanting a pet's DNA into a donor egg and growing it in a surrogate.
technologyreview.com
· 2026-10-16
GoKawiil